Arvinas (ARVN) Research & Development (2017 - 2026)

Arvinas' (ARVN) quarterly Research & Development came in at $60.3 million in Q1 2026, down 33.59% year-on-year from $90.8 million in Q1 2025, and down 1.31% quarter-over-quarter from $61.1 million in Q4 2025.

Arvinas (ARVN) Research & Development (2017 - 2026) Analysis & Trends

Arvinas' Research & Development history runs 10 years deep, the most recent figure standing at $60.3 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 33.59% year-over-year to $60.3 million in Q1 2026; TTM through Mar 2026 was $254.7 million, a 28.19% decrease from a year earlier, with the FY2025 full-year figure at $285.2 million, down 18.09% from the prior year.
  • Research & Development declined to $60.3 million in Q1 2026 per ARVN's latest filing, from $61.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $103.4 million in Q2 2023 and bottomed at $60.3 million in Q1 2026.
  • The 5-year median for Research & Development is $84.3 million (2024), against an average of $81.7 million.
  • Across the five-year window, Research & Development jumped 90.89% in 2022 and plunged 33.59% in 2026, its largest moves.
  • Year by year, Research & Development stood at $98.3 million in 2022, then fell by 3.15% to $95.2 million in 2023, then dropped by 12.5% to $83.3 million in 2024, then slipped by 26.65% to $61.1 million in 2025, then retreated by 1.31% to $60.3 million in 2026.
  • Per Business Quant, the three latest ARVN Research & Development figures stand at $60.3 million (Q1 2026), $61.1 million (Q4 2025), and $64.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 Arvinas 512.64 Mn -102.26 Mn - 60.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.30 Mn
Dec 31, 2025 61.10 Mn
Sep 30, 2025 64.70 Mn
Jun 30, 2025 68.60 Mn
Mar 31, 2025 90.80 Mn
Dec 31, 2024 83.30 Mn
Sep 30, 2024 86.90 Mn
Jun 30, 2024 93.70 Mn
Mar 31, 2024 84.30 Mn
Dec 31, 2023 95.20 Mn
Sep 30, 2023 85.90 Mn
Jun 30, 2023 103.40 Mn
Mar 31, 2023 95.30 Mn
Dec 31, 2022 98.30 Mn
Sep 30, 2022 77.50 Mn
Jun 30, 2022 75.30 Mn
Mar 31, 2022 64.00 Mn
Dec 31, 2021 61.90 Mn
Sep 30, 2021 40.60 Mn
Jun 30, 2021 43.00 Mn